{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:48:49Z","timestamp":1791186529091,"version":"4.1.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T00:00:00Z","timestamp":1296172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s10555-011-9279-y","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T01:24:53Z","timestamp":1296091493000},"page":"13-25","source":"Crossref","is-referenced-by-count":107,"title":["Tumor microenvironment is multifaceted"],"prefix":"10.1007","volume":"30","author":[{"given":"Catherine","family":"Saut\u00e8s-Fridman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Cherfils-Vicini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Damotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Fisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf Herv\u00e9","family":"Fridman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Caroline","family":"Dieu-Nosjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,28]]},"reference":[{"key":"9279_CR1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill, F. (2009). Tumour necrosis factor and cancer. Nature Reviews Cancer, 9, 361\u2013371.","journal-title":"Nature Reviews Cancer"},{"key":"9279_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0003-9861(03)00283-2","volume":"417","author":"H Ohshima","year":"2003","unstructured":"Ohshima, H., Tatemichi, M., & Sawa, T. (2003). Chemical basis of inflammation-induced carcinogenesis. Archives of Biochemistry and Biophysics, 417, 3\u201311.","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"9279_CR3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin, M., & Greten, F. R. (2005). NF-kappaB: linking inflammation and immunity to cancer development and progression. Nature Reviews Immunology, 5, 749\u2013759.","journal-title":"Nature Reviews Immunology"},{"key":"9279_CR4","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1172\/JCI31537","volume":"117","author":"W-W Lin","year":"2007","unstructured":"Lin, W.-W., & Karin, M. (2007). A cytokine-mediated link between innate immunity, inflammation, and cancer. Journal of Clinical Investigation, 117, 1175\u20131183.","journal-title":"Journal of Clinical Investigation"},{"key":"9279_CR5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill, F., & Mantovani, A. (2001). Inflammation and cancer: back to Virchow? Lancet, 357, 539\u2013545.","journal-title":"Lancet"},{"key":"9279_CR6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens, L. M., & Werb, Z. (2002). Inflammation and cancer. Nature, 420, 860\u2013867.","journal-title":"Nature"},{"key":"9279_CR7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ijc.2910630210","volume":"63","author":"E Tartour","year":"1995","unstructured":"Tartour, E., Latour, S., Mathiot, C., Thiounn, N., Mosseri, V., Joyeux, I., et al. (1995). Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. International Journal of Cancer, 63, 205\u2013212.","journal-title":"International Journal of Cancer"},{"key":"9279_CR8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/10428199909169619","volume":"35","author":"I Frydecka","year":"1999","unstructured":"Frydecka, I., Kaczmarek, P., Bo\u0107ko, D., Kosmaczewska, A., Morilla, R., & Catovsky, D. (1999). Expression of signal-transducing zeta chain in peripheral blood T cells and natural killer cells in patients with Hodgkin\u2019s disease in different phases of the disease. Leukaemia & Lymphoma, 35, 545\u2013554.","journal-title":"Leukaemia & Lymphoma"},{"key":"9279_CR9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/ni975","volume":"4","author":"N Bronstein-Sitton","year":"2003","unstructured":"Bronstein-Sitton, N., Cohen-Daniel, L., Vaknin, I., Ezernitchi, A. V., Leshem, B., Halabi, A., et al. (2003). Sustained exposure to bacterial antigen induces interferon-gamma-dependent T cell receptor zeta down-regulation and impaired T cell function. Nature Immunology, 4, 957\u2013964.","journal-title":"Nature Immunology"},{"issue":"4","key":"9279_CR10","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1172\/JCI36551","volume":"120","author":"J Cherfils-Vicini","year":"2010","unstructured":"Cherfils-Vicini, J., Platonova, S., Gillard, M., Laurans, L., Validire, P., Caliandro, R., et al. (2010). Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance. The Journal of Clinical Investigation, 120(4), 1285\u20131297.","journal-title":"The Journal of Clinical Investigation"},{"key":"9279_CR11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nri1961","volume":"6","author":"GP Dunn","year":"2006","unstructured":"Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006). Interferons, immunity and cancer immunoediting. Nature Reviews Immunology, 6, 836\u2013848.","journal-title":"Nature Reviews Immunology"},{"key":"9279_CR12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.1.5023.841","volume":"1","author":"M BURNET","year":"1957","unstructured":"BURNET, M. (1957). Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications. British Medical Journal, 1, 841\u2013847.","journal-title":"British Medical Journal"},{"key":"9279_CR13","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pag\u00e8s, C., et al. (2006). Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science, 313, 1960\u20131964.","journal-title":"Science"},{"key":"9279_CR14","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa051424","volume":"353","author":"F Pag\u00e8s","year":"2005","unstructured":"Pag\u00e8s, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., et al. (2005). Effector memory T cells, early metastasis, and survival in colorectal cancer. The New England Journal of Medicine, 353, 2654\u20132666.","journal-title":"The New England Journal of Medicine"},{"key":"9279_CR15","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","volume":"26","author":"M-C Dieu-Nosjean","year":"2008","unstructured":"Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., et al. (2008). Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. Journal of Clinical Oncology, 26, 4410\u20134417.","journal-title":"Journal of Clinical Oncology"},{"key":"9279_CR16","doi-asserted-by":"crossref","unstructured":"Fridman, W. H., Galon, J., Dieu-Nosjean, M.-C., Cremer, I., Fisson, S., Damotte, D., Pag\u00e8s, F., Tartour, E., Saut\u00e8s-Fridman, C. (2010). Immune infiltration in human cancer: prognostic significance and disease control. Current topics in Microbiology and Immunology","DOI":"10.1007\/82_2010_46"},{"key":"9279_CR17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau, J., & Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature, 392, 245\u2013252.","journal-title":"Nature"},{"key":"9279_CR18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.immuni.2008.07.013","volume":"29","author":"E Klechevsky","year":"2008","unstructured":"Klechevsky, E., Morita, R., Liu, M., Cao, Y., Coquery, S., Thompson-Snipes, L., et al. (2008). Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity, 29, 497\u2013510.","journal-title":"Immunity"},{"key":"9279_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.bjc.6690021","volume":"79","author":"C M\u00e9n\u00e9trier-Caux","year":"1999","unstructured":"M\u00e9n\u00e9trier-Caux, C., Bain, C., Favrot, M. C., Duc, A., & Blay, J. Y. (1999). Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes. British Journal of Cancer, 79, 119\u2013130.","journal-title":"British Journal of Cancer"},{"key":"9279_CR20","first-page":"1755","volume":"6","author":"B Almand","year":"2000","unstructured":"Almand, B., Resser, J. R., Lindman, B., Nadaf, S., Clark, J. I., Kwon, E. D., et al. (2000). Clinical significance of defective dendritic cell differentiation in cancer. Clinical Cancer Research, 6, 1755\u20131766.","journal-title":"Clinical Cancer Research"},{"key":"9279_CR21","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/sj.bjc.6600132","volume":"86","author":"BJ Coventry","year":"2002","unstructured":"Coventry, B. J., Lee, P.-L., Gibbs, D., & Hart, D. N. J. (2002). Dendritic cell density and activation status in human breast cancer\u2014CD1a, CMRF-44, CMRF-56 and CD-83 expression. British Journal of Cancer, 86, 546\u2013551.","journal-title":"British Journal of Cancer"},{"key":"9279_CR22","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1096-1096","volume":"2","author":"DI Gabrilovich","year":"1996","unstructured":"Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., et al. (1996). Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Natural Medicines, 2, 1096\u20131103.","journal-title":"Natural Medicines"},{"key":"9279_CR23","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1158\/0008-5472.CAN-03-2969","volume":"64","author":"M Movassagh","year":"2004","unstructured":"Movassagh, M., Spatz, A., Davoust, J., Lebecque, S., Romero, P., Pittet, M., et al. (2004). Selective accumulation of mature DC-Lamp\u2009+\u2009dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma. Cancer Research, 64, 2192\u20132198.","journal-title":"Cancer Research"},{"key":"9279_CR24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1344","volume":"200","author":"W Vermi","year":"2003","unstructured":"Vermi, W., Bonecchi, R., Facchetti, F., Bianchi, D., Sozzani, S., Festa, S., et al. (2003). Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. The Journal of Pathology, 200, 255\u2013268.","journal-title":"The Journal of Pathology"},{"key":"9279_CR25","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1084\/jem.190.10.1417","volume":"190","author":"D Bell","year":"1999","unstructured":"Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G. M., Lebecque, S., et al. (1999). In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. The Journal of Experimental Medicine, 190, 1417\u20131426.","journal-title":"The Journal of Experimental Medicine"},{"key":"9279_CR26","first-page":"353","volume":"14","author":"M Furihata","year":"2005","unstructured":"Furihata, M., Ono, Y., Ichikawa, K., Tomita, S., Fujimori, T., & Kubota, K. (2005). Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma. Oncology Reports, 14, 353\u2013356.","journal-title":"Oncology Reports"},{"key":"9279_CR27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00002371-200103000-00007","volume":"24","author":"T Schwaab","year":"2001","unstructured":"Schwaab, T., Weiss, J. E., Schned, A. R., & Barth, R. J., Jr. (2001). Dendritic cell infiltration in colon cancer. Journal of Immunotherapy, 24, 130\u2013137.","journal-title":"Journal of Immunotherapy"},{"key":"9279_CR28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1053\/hupa.2001.26455","volume":"32","author":"A Eisenthal","year":"2001","unstructured":"Eisenthal, A., Polyvkin, N., Bramante-Schreiber, L., Misonznik, F., Hassner, A., & Lifschitz-Mercer, B. (2001). Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer. Human Pathology, 32, 803\u2013807.","journal-title":"Human Pathology"},{"key":"9279_CR29","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/1097-0142(20010601)91:11<2136::AID-CNCR1242>3.0.CO;2-Q","volume":"91","author":"TE Reichert","year":"2001","unstructured":"Reichert, T. E., Scheuer, C., Day, R., Wagner, W., & Whiteside, T. L. (2001). The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer, 91, 2136\u20132147.","journal-title":"Cancer"},{"key":"9279_CR30","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1158\/1078-0432.CCR-04-0684","volume":"10","author":"I Treilleux","year":"2004","unstructured":"Treilleux, I., Blay, J.-Y., Bendriss-Vermare, N., Ray-Coquard, I., Bachelot, T., Guastalla, J.-P., et al. (2004). Dendritic cell infiltration and prognosis of early stage breast cancer. Clinical Cancer Research, 10, 7466\u20137474.","journal-title":"Clinical Cancer Research"},{"key":"9279_CR31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","volume":"27","author":"S Vallabhapurapu","year":"2009","unstructured":"Vallabhapurapu, S., & Karin, M. (2009). Regulation and function of NF-kappaB transcription factors in the immune system. Annual Review of Immunology, 27, 693\u2013733.","journal-title":"Annual Review of Immunology"},{"key":"9279_CR32","first-page":"40422","volume":"49","author":"X Li","year":"2010","unstructured":"Li, X., Jiang, S., & Tapping, R. (2010). Toll-like receptor signaling in cell proliferation and survival. Cytokine, 49, 40422.","journal-title":"Cytokine"},{"key":"9279_CR33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.1140488","volume":"317","author":"S Rakoff-Nahoum","year":"2007","unstructured":"Rakoff-Nahoum, S., & Medzhitov, R. (2007). Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science, 317, 124\u2013127.","journal-title":"Science"},{"key":"9279_CR34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.immuni.2007.02.012","volume":"26","author":"H Xiao","year":"2007","unstructured":"Xiao, H., Gulen, M. F., Qin, J., Yao, J., Bulek, K., Kish, D., et al. (2007). The toll\u2013interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity, 26, 461\u2013475.","journal-title":"Immunity"},{"key":"9279_CR35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/sj.onc.1210904","volume":"27","author":"B Huang","year":"2008","unstructured":"Huang, B., Zhao, J., Unkeless, J. C., Feng, Z. H., & Xiong, H. (2008). TLR signaling by tumor and immune cells: a double-edged sword. Oncogene, 27, 218\u2013224.","journal-title":"Oncogene"},{"issue":"8","key":"9279_CR36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/jso.21392","volume":"100","author":"M Ikebe","year":"2009","unstructured":"Ikebe, M., Kitaura, Y., Nakamura, M., Tanaka, H., Yamasaki, A., Nagai, S., et al. (2009). Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4\/MyD88 signaling pathway. Journal of Surgical Oncology, 100(8), 725\u2013731.","journal-title":"Journal of Surgical Oncology"},{"key":"9279_CR37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.bjc.6603275","volume":"95","author":"SD Killeen","year":"2006","unstructured":"Killeen, S. D., Wang, J. H., Andrews, E. J., & Redmond, H. P. (2006). Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword? British Journal of Cancer, 95, 247\u2013252.","journal-title":"British Journal of Cancer"},{"key":"9279_CR38","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1158\/0008-5472.CAN-05-3948","volume":"66","author":"MG Kelly","year":"2006","unstructured":"Kelly, M. G., Alvero, A. B., Chen, R., Silasi, D.-A., Abrahams, V. M., Chan, S., et al. (2006). TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Research, 66, 3859\u20133868.","journal-title":"Cancer Research"},{"key":"9279_CR39","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/onc.2009.289","volume":"28","author":"M Szajnik","year":"2009","unstructured":"Szajnik, M., Szczepanski, M., Czystowska, M., Elishaev, E., Mandapathil, M., Nowak-Markwitz, E., et al. (2009). TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer. Oncogene, 28, 4353\u20134363.","journal-title":"Oncogene"},{"key":"9279_CR40","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.molimm.2007.01.022","volume":"44","author":"W He","year":"2007","unstructured":"He, W., Liu, Q., Wang, L., Chen, W., Li, N., & Cao, X. (2007). TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Molecular Immunology, 44, 2850\u20132859.","journal-title":"Molecular Immunology"},{"key":"9279_CR41","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1158\/0008-5472.CAN-05-0784","volume":"65","author":"B Huang","year":"2005","unstructured":"Huang, B., Zhao, J., Li, H., He, K.-L., Chen, Y., Chen, S.-H., et al. (2005). Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Research, 65, 5009\u20135014.","journal-title":"Cancer Research"},{"key":"9279_CR42","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1158\/1078-0432.CCR-04-1890","volume":"11","author":"B Jahrsdorfer","year":"2005","unstructured":"Jahrsdorfer, B., M\u00fchlenhoff, L., Blackwell, S. E., Wagner, M., Poeck, H., Hartmann, E., et al. (2005). B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides. Clinical Cancer Research, 11, 1490\u20131499.","journal-title":"Clinical Cancer Research"},{"key":"9279_CR43","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.4049\/jimmunol.176.8.4894","volume":"176","author":"B Salaun","year":"2006","unstructured":"Salaun, B., Coste, I., Rissoan, M.-C., Lebecque, S. J., & Renno, T. (2006). TLR3 can directly trigger apoptosis in human cancer cells. Journal of Immunology, 176, 4894\u20134901.","journal-title":"Journal of Immunology"},{"key":"9279_CR44","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1158\/1078-0432.CCR-07-0274","volume":"13","author":"B Salaun","year":"2007","unstructured":"Salaun, B., Lebecque, S., Matikainen, S., Rimoldi, D., & Romero, P. (2007). Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clinical Cancer Research, 13, 4565\u20134574.","journal-title":"Clinical Cancer Research"},{"key":"9279_CR45","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1002\/eji.200737744","volume":"37","author":"B Salaun","year":"2007","unstructured":"Salaun, B., Romero, P., & Lebecque, S. (2007). Toll-like receptors\u2019 two-edged sword: when immunity meets apoptosis. European Journal of Immunology, 37, 3311\u20133318.","journal-title":"European Journal of Immunology"},{"key":"9279_CR46","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.intimp.2007.05.016","volume":"7","author":"K Chen","year":"2007","unstructured":"Chen, K., Huang, J., Gong, W., Iribarren, P., Dunlop, N. M., & Wang, J. M. (2007). Toll-like receptors in inflammation, infection and cancer. International Immunopharmacology, 7, 1271\u20131285.","journal-title":"International Immunopharmacology"},{"key":"9279_CR47","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1172\/JCI31414","volume":"117","author":"AM Krieg","year":"2007","unstructured":"Krieg, A. M. (2007). Development of TLR9 agonists for cancer therapy. Journal of Clinical Investigation, 117, 1184\u20131194.","journal-title":"Journal of Clinical Investigation"},{"key":"9279_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20090272","volume":"420","author":"H Kumar","year":"2009","unstructured":"Kumar, H., Kawai, T., & Akira, S. (2009). Pathogen recognition in the innate immune response. The Biochemical Journal, 420, 1\u201316.","journal-title":"The Biochemical Journal"},{"key":"9279_CR49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semcancer.2005.07.004","volume":"16","author":"M-F Tsan","year":"2006","unstructured":"Tsan, M.-F. (2006). Toll-like receptors, inflammation and cancer. Seminars in Cancer Biology, 16, 32\u201337.","journal-title":"Seminars in Cancer Biology"},{"key":"9279_CR50","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nm1589","volume":"13","author":"H Kanzler","year":"2007","unstructured":"Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007). Therapeutic targeting of innate immunity with toll-like receptor agonists and antagonists. Natural Medicines, 13, 552\u2013559.","journal-title":"Natural Medicines"},{"key":"9279_CR51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrc2541","volume":"9","author":"S Rakoff-Nahoum","year":"2009","unstructured":"Rakoff-Nahoum, S., & Medzhitov, R. (2009). Toll-like receptors and cancer. Nature Reviews Cancer, 9, 57\u201363.","journal-title":"Nature Reviews Cancer"},{"key":"9279_CR52","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.onc.1210913","volume":"27","author":"MP Sch\u00f6n","year":"2008","unstructured":"Sch\u00f6n, M. P., & Sch\u00f6n, M. (2008). TLR7 and TLR8 as targets in cancer therapy. Oncogene, 27, 190\u2013199.","journal-title":"Oncogene"},{"key":"9279_CR53","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1158\/1055-9965.EPI-04-0599","volume":"14","author":"AJ Littman","year":"2005","unstructured":"Littman, A. J., Jackson, L. A., & Vaughan, T. L. (2005). Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomarkers and Prevention, 14, 773\u2013778.","journal-title":"Cancer Epidemiol Biomarkers and Prevention"},{"key":"9279_CR54","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1023\/B:CACO.0000043432.71626.45","volume":"15","author":"AJ Littman","year":"2004","unstructured":"Littman, A. J., Thornquist, M. D., White, E., Jackson, L. A., Goodman, G. E., & Vaughan, T. L. (2004). Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes & Control, 15, 819\u2013827.","journal-title":"Cancer Causes & Control"},{"key":"9279_CR55","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1158\/1055-9965.1624.13.10","volume":"13","author":"AJ Littman","year":"2004","unstructured":"Littman, A. J., White, E., Jackson, L. A., Thornquist, M. D., Gaydos, C. A., Goodman, G. E., et al. (2004). Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers and Prevention, 13, 1624\u20131630.","journal-title":"Cancer Epidemiol Biomarkers and Prevention"},{"key":"9279_CR56","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.semcancer.2004.06.006","volume":"14","author":"M Philip","year":"2004","unstructured":"Philip, M., Rowley, D. A., & Schreiber, H. (2004). Inflammation as a tumor promoter in cancer induction. Seminars in Cancer Biology, 14, 433\u2013439.","journal-title":"Seminars in Cancer Biology"},{"key":"9279_CR57","doi-asserted-by":"crossref","first-page":"21013","DOI":"10.1074\/jbc.M512908200","volume":"281","author":"J Qin","year":"2006","unstructured":"Qin, J., Yao, J., Cui, G., Xiao, H., Kim, T. W., Fraczek, J., et al. (2006). TLR8-mediated NF-kappaB and JNK activation are TAK1-independent and MEKK3-dependent. The Journal of Biological Chemistry, 281, 21013\u201321021.","journal-title":"The Journal of Biological Chemistry"},{"key":"9279_CR58","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1158\/0008-5472.CAN-06-4067","volume":"67","author":"B Huang","year":"2007","unstructured":"Huang, B., Zhao, J., Shen, S., Li, H., He, K.-L., Shen, G.-X., et al. (2007). Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Research, 67, 4346\u20134352.","journal-title":"Cancer Research"},{"key":"9279_CR59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2004.08.012","volume":"6","author":"J-L Luo","year":"2004","unstructured":"Luo, J.-L., Maeda, S., Hsu, L.-C., Yagita, H., & Karin, M. (2004). Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell, 6, 297\u2013305.","journal-title":"Cancer Cell"},{"key":"9279_CR60","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.4049\/jimmunol.176.11.6624","volume":"176","author":"L Sfondrini","year":"2006","unstructured":"Sfondrini, L., Rossini, A., Besusso, D., Merlo, A., Tagliabue, E., M\u00e8nard, S., et al. (2006). Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer. Journal of Immunology, 176, 6624\u20136630.","journal-title":"Journal of Immunology"},{"key":"9279_CR61","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1245\/s10434-009-0325-8","volume":"16","author":"T Earl","year":"2009","unstructured":"Earl, T., Nicoud, I., Pierce, J., Wright, J., Majoras, N., Rubin, J., et al. (2009). Silencing of TLR4 Decreases Liver Tumor Burden in a Murine Model of Colorectal Metastasis and Hepatic Steatosis. Annals of Surgical Oncology, 16, 1043\u20131050.","journal-title":"Annals of Surgical Oncology"},{"key":"9279_CR62","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2009.356","volume":"29","author":"A Tesniere","year":"2010","unstructured":"Tesniere, A., Schlemmer, F., Boige, V., Kepp, O., Martins, I., Ghiringhelli, F., et al. (2010). Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene, 29, 482\u2013491.","journal-title":"Oncogene"},{"key":"9279_CR63","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.4049\/jimmunol.0803113","volume":"182","author":"D Chiron","year":"2009","unstructured":"Chiron, D., Pellat-Deceunynck, C., Amiot, M., Bataille, R., & Jego, G. (2009). TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production. Journal of Immunology, 182, 4471\u20134478.","journal-title":"Journal of Immunology"},{"key":"9279_CR64","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.4049\/jimmunol.0901386","volume":"183","author":"Q Wang","year":"2009","unstructured":"Wang, Q., Nagarkar, D., Bowman, E., Schneider, D., Gosangi, B., Lei, J., et al. (2009). Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. Journal of Immunology, 183, 6989\u20136997.","journal-title":"Journal of Immunology"},{"key":"9279_CR65","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1349-7006.2008.01062.x","volume":"100","author":"S Peng","year":"2008","unstructured":"Peng, S., Geng, J., Sun, R., Tian, Z., & Wei, H. (2008). Polyinosinic-polycytidylic acid liposome induces human hepatoma cells apoptosis which correlates to the up-regulation of RIG-I like receptors. Cancer Science, 100, 529\u2013536.","journal-title":"Cancer Science"},{"key":"9279_CR66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00737075","volume":"407","author":"T Nakajima","year":"1985","unstructured":"Nakajima, T., Kodama, T., Tsumuraya, M., Shimosato, Y., & Kameya, T. (1985). S-100 protein-positive Langerhans cells in various human lung cancers, especially in peripheral adenocarcinomas. Virchows Archiv. A, Pathological Anatomy and Histopathology, 407, 177\u2013189.","journal-title":"Virchows Archiv. A, Pathological Anatomy and Histopathology"},{"key":"9279_CR67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1165\/rcmb.2004-0279OC","volume":"32","author":"IK Demedts","year":"2005","unstructured":"Demedts, I. K., Brusselle, G. G., Vermaelen, K. Y., & Pauwels, R. A. (2005). Identification and characterization of human pulmonary dendritic cells. American Journal of Respiratory Cell and Molecular Biology, 32, 177\u2013184.","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"9279_CR68","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1172\/JCI116236","volume":"91","author":"A Tazi","year":"1993","unstructured":"Tazi, A., Bouchonnet, F., Grandsaigne, M., Boumsell, L., Hance, A. J., & Soler, P. (1993). Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells\/Langerhans cells in human lung and lung cancers. The Journal of Clinical Investigation, 91, 566\u2013576.","journal-title":"The Journal of Clinical Investigation"},{"key":"9279_CR69","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1399-0039.1998.tb03098.x","volume":"51","author":"C Asselin-Paturel","year":"1998","unstructured":"Asselin-Paturel, C., Pardoux, C., Gay, F., & Chouaib, S. (1998). Failure of TGF beta1 and IL-12 to regulate human FasL and mTNF alloreactive cytotoxic T-cell pathways. Tissue Antigens, 51, 242\u2013249.","journal-title":"Tissue Antigens"},{"key":"9279_CR70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s002620050603","volume":"49","author":"DA Arenberg","year":"2000","unstructured":"Arenberg, D. A., Keane, M. P., DiGiovine, B., Kunkel, S. L., Strom, S. R., Burdick, M. D., et al. (2000). Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunology, Immunotherapy, 49, 63\u201370.","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"9279_CR71","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1158\/0008-5472.CAN-03-3262","volume":"64","author":"M P\u00f5ld","year":"2004","unstructured":"P\u00f5ld, M., Zhu, L. X., Sharma, S., Burdick, M. D., Lin, Y., Lee, P. P. N., et al. (2004). Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78\/CXC Ligand (CXCL) 5 and interleukin-8\/CXCL8 in human non-small cell lung cancer. Cancer Research, 64, 1853\u20131860.","journal-title":"Cancer Research"},{"key":"9279_CR72","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1002\/eji.200636499","volume":"37","author":"T Cao","year":"2007","unstructured":"Cao, T., Ueno, H., Glaser, C., Fay, J. W., Palucka, A. K., & Banchereau, J. (2007). Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL. European Journal of Immunology, 37, 2657\u20132667.","journal-title":"European Journal of Immunology"},{"key":"9279_CR73","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.4049\/jimmunol.176.10.5735","volume":"176","author":"J Marchal-Somm\u00e9","year":"2006","unstructured":"Marchal-Somm\u00e9, J., Uzunhan, Y., Marchand-Adam, S., Valeyre, D., Soumelis, V., Crestani, B., et al. (2006). Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. Journal of Immunology, 176, 5735\u20135739.","journal-title":"Journal of Immunology"},{"key":"9279_CR74","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1349-7006.2003.tb01392.x","volume":"94","author":"O Wakabayashi","year":"2003","unstructured":"Wakabayashi, O., Yamazaki, K., Oizumi, S., Hommura, F., Kinoshita, I., Ogura, S., et al. (2003). CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Science, 94, 1003\u20131009.","journal-title":"Cancer Science"},{"key":"9279_CR75","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jnci\/90.4.287","volume":"90","author":"E Tartour","year":"1998","unstructured":"Tartour, E., Gey, A., Sastre-Garau, X., Lombard Surin, I., Mosseri, V., & Fridman, W. H. (1998). Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. Journal of the National Cancer Institute, 90, 287\u2013294.","journal-title":"Journal of the National Cancer Institute"},{"key":"9279_CR76","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ni1029","volume":"5","author":"P Yu","year":"2004","unstructured":"Yu, P., Lee, Y., Liu, W., Chin, R. K., Wang, J., Wang, Y., et al. (2004). Priming of naive T cells inside tumors leads to eradication of established tumors. Nature Immunology, 5, 141\u2013149.","journal-title":"Nature Immunology"},{"key":"9279_CR77","first-page":"2062","volume":"61","author":"CJ Kirk","year":"2001","unstructured":"Kirk, C. J., Hartigan-O\u2019Connor, D., Nickoloff, B. J., Chamberlain, J. S., Giedlin, M., Aukerman, L., et al. (2001). T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. Cancer Research, 61, 2062\u20132070.","journal-title":"Cancer Research"},{"key":"9279_CR78","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nm1091","volume":"10","author":"JE Moyron-Quiroz","year":"2004","unstructured":"Moyron-Quiroz, J. E., Rangel-Moreno, J., Kusser, K., Hartson, L., Sprague, F., Goodrich, S., et al. (2004). Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Natural Medicines, 10, 927\u2013934.","journal-title":"Natural Medicines"},{"key":"9279_CR79","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.4049\/jimmunol.173.7.4377","volume":"173","author":"BM Tesar","year":"2004","unstructured":"Tesar, B. M., Chalasani, G., Smith-Diggs, L., Baddoura, F. K., Lakkis, F. G., & Goldstein, D. R. (2004). Direct antigen presentation by a xenograft induces immunity independently of secondary lymphoid organs. Journal of Immunology, 173, 4377\u20134386.","journal-title":"Journal of Immunology"},{"key":"9279_CR80","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.immuni.2006.08.022","volume":"25","author":"JE Moyron-Quiroz","year":"2006","unstructured":"Moyron-Quiroz, J. E., Rangel-Moreno, J., Hartson, L., Kusser, K., Tighe, M. P., Klonowski, K. D., et al. (2006). Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity, 25, 643\u2013654.","journal-title":"Immunity"},{"key":"9279_CR81","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ni1330","volume":"7","author":"DL Drayton","year":"2006","unstructured":"Drayton, D. L., Liao, S., Mounzer, R. H., & Ruddle, N. H. (2006). Lymphoid organ development: from ontogeny to neogenesis. Nature Immunology, 7, 344\u2013353.","journal-title":"Nature Immunology"},{"key":"9279_CR82","first-page":"13","volume":"26","author":"J Rangel-Moreno","year":"2007","unstructured":"Rangel-Moreno, J., Carragher, D., & Randall, T. D. (2007). Role of lymphotoxin and homeostatic chemokines in the development and function of local lymphoid tissues in the respiratory tract. Inmunologia (Barcelona, Spain: 1987), 26, 13\u201328.","journal-title":"Inmunologia (Barcelona, Spain : 1987)"},{"key":"9279_CR83","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1084\/jem.20090410","volume":"206","author":"CH GeurtsvanKessel","year":"2009","unstructured":"GeurtsvanKessel, C. H., Willart, M. A. M., Bergen, I. M., van Rijt, L. S., Muskens, F., Elewaut, D., et al. (2009). Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. The Journal of Experimental Medicine, 206, 2339\u20132349.","journal-title":"The Journal of Experimental Medicine"},{"key":"9279_CR84","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.20091472","volume":"206","author":"S Halle","year":"2009","unstructured":"Halle, S., Dujardin, H. C., Bakocevic, N., Fleige, H., Danzer, H., Willenzon, S., et al. (2009). Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. The Journal of Experimental Medicine, 206, 2593\u20132601.","journal-title":"The Journal of Experimental Medicine"},{"key":"9279_CR85","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1076\/ocii.8.4.243.6463","volume":"8","author":"N Cassoux","year":"2000","unstructured":"Cassoux, N., Merle-Beral, H., Leblond, V., Bodaghi, B., Mil\u00e9a, D., Gerber, S., et al. (2000). Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocular Immunology and Inflammation, 8, 243\u2013250.","journal-title":"Ocular Immunology and Inflammation"},{"key":"9279_CR86","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00347-003-0855-6","volume":"101","author":"SE Coupland","year":"2004","unstructured":"Coupland, S. E., & Heimann, H. (2004). Primary intraocular lymphoma. Der Ophthalmologe, 101, 87\u201398.","journal-title":"Der Ophthalmologe"},{"key":"9279_CR87","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1158\/0008-5472.CAN-08-2761","volume":"69","author":"SM Pantanelli","year":"2009","unstructured":"Pantanelli, S. M., Li, Z., Fariss, R., Mahesh, S. P., Liu, B., & Nussenblatt, R. B. (2009). Differentiation of malignant B-lymphoma cells from normal and activated T-cell populations by their intrinsic autofluorescence. Cancer Research, 69, 4911\u20134917.","journal-title":"Cancer Research"},{"key":"9279_CR88","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1167\/iovs.07-0008","volume":"48","author":"V Touitou","year":"2007","unstructured":"Touitou, V., Daussy, C., Bodaghi, B., Camelo, S., de Kozak, Y., Lehoang, P., et al. (2007). Impaired th1\/tc1 cytokine production of tumor-infiltrating lymphocytes in a model of primary intraocular B-cell lymphoma. Investigative Ophthalmology & Visual Science, 48, 3223\u20133229.","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"9279_CR89","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0161-6420(99)90341-X","volume":"106","author":"EK Akpek","year":"1999","unstructured":"Akpek, E. K., Ahmed, I., Hochberg, F. H., Soheilian, M., Dryja, T. P., Jakobiec, F. A., et al. (1999). Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology, 106, 1805\u20131810.","journal-title":"Ophthalmology"},{"key":"9279_CR90","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0161-6420(99)90528-6","volume":"106","author":"EK Akpek","year":"1999","unstructured":"Akpek, E. K., Maca, S. M., Christen, W. G., & Foster, C. S. (1999). Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma. Ophthalmology, 106, 2291\u20132295.","journal-title":"Ophthalmology"},{"key":"9279_CR91","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/bjo.72.12.905","volume":"72","author":"DH Char","year":"1988","unstructured":"Char, D. H., Ljung, B. M., Desch\u00eanes, J., & Miller, T. R. (1988). Intraocular lymphoma: immunological and cytological analysis. The British Journal of Ophthalmology, 72, 905\u2013911.","journal-title":"The British Journal of Ophthalmology"},{"key":"9279_CR92","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0161-6420(88)33145-3","volume":"95","author":"DH Char","year":"1988","unstructured":"Char, D. H., Ljung, B. M., Miller, T., & Phillips, T. (1988). Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology, 95, 625\u2013630.","journal-title":"Ophthalmology"},{"key":"9279_CR93","first-page":"144","volume":"21","author":"C Corriveau","year":"1986","unstructured":"Corriveau, C., Easterbrook, M., & Payne, D. (1986). Lymphoma simulating uveitis (masquerade syndrome). Canadian Journal of Ophthalmology, 21, 144\u2013149.","journal-title":"Canadian Journal of Ophthalmology"},{"key":"9279_CR94","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1442-9071.2008.01843.x","volume":"36","author":"SE Coupland","year":"2008","unstructured":"Coupland, S. E., & Damato, B. (2008). Understanding intraocular lymphomas. Clin Experiment Ophthalmol, 36, 564\u2013578.","journal-title":"Clin Experiment Ophthalmol"},{"key":"9279_CR95","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/onc.2009.416","volume":"29","author":"F Pag\u00e8s","year":"2010","unstructured":"Pag\u00e8s, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Saut\u00e8s-Fridman, C., & Fridman, W.-H. (2010). Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene, 29, 1093\u20131102.","journal-title":"Oncogene"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-011-9279-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10555-011-9279-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-011-9279-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:05:57Z","timestamp":1685923557000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10555-011-9279-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,28]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9279"],"URL":"https:\/\/doi.org\/10.1007\/s10555-011-9279-y","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,28]]}}}